特应性疾病与韩国炎症性肠病发病相关:一项全国性人群研究
该研究纳入2009年接受体检的9,923,521名韩国人并随访至2017年,评估特应性皮炎、过敏性鼻炎和哮喘与炎症性肠病发病的关联。平均随访7.3年,特应性疾病患者克罗恩病和溃疡性结肠炎风险均升高,且风险随特应性疾病数量增加而升高。
要点
- 特应性皮炎、过敏性鼻炎和哮喘患者克罗恩病风险均升高,aHR分别为2.02、1.33和1.60。
- 特应性皮炎、过敏性鼻炎和哮喘患者溃疡性结肠炎风险均升高,aHR分别为1.51、1.32和1.29。
- 特应性疾病数量增加时,克罗恩病和溃疡性结肠炎风险逐渐升高。
核心结论
- 在韩国全国性人群中,任何特应性疾病(包括特应性皮炎、过敏性鼻炎或哮喘)患者克罗恩病和溃疡性结肠炎风险均升高。
- 炎症性肠病风险随特应性疾病数量增加而升高。
研究设计与样本
- 韩国全国性人群研究,纳入2009年接受体检的9,923,521名参与者,随访至2017年。
- 通过国民健康保险理赔数据识别新发克罗恩病和溃疡性结肠炎,采用Cox比例风险模型评估关联,以aHR和95%CI表示。
主要发现
- 平均随访7.3年,1419例(0.014%)发生克罗恩病,5897例(0.059%)发生溃疡性结肠炎。
- 特应性皮炎、过敏性鼻炎和哮喘患者的克罗恩病发病率(每10万人年)分别为3.756、2.248和2.346。
- 特应性皮炎、过敏性鼻炎和哮喘患者的溃疡性结肠炎发病率(每10万人年)分别为11.952、9.818和9.358。
- 与对照相比,特应性皮炎、过敏性鼻炎和哮喘患者克罗恩病aHR分别为2.02(95%CI 1.118-3.663)、1.33(95%CI 1.149-1.529)和1.60(95%CI 1.193-2.136)。
- 与对照相比,特应性皮炎、过敏性鼻炎和哮喘患者溃疡性结肠炎aHR分别为1.51(95%CI 1.082-2.104)、1.32(95%CI 1.229-1.410)和1.29(95%CI 1.115-1.491)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The association between atopic diseases and inflammatory bowel diseases (IBD) is unclear. We conducted a nationwide population-based study in Korea to investigate the effect of atopic diseases on the development of IBD. METHODS: A total of 9,923,521 participants, who received a medical check-up in 2009, were included and followed through 2017. The presence of any atopic diseases, including atopic dermatitis (AD), allergic rhinitis (AR), and asthma, was evaluated. Patients who developed IBD, including Crohn's disease (CD) and ulcerative colitis (UC), were identified using claims data from National Health Insurance; the association between atopic diseases and the risk of IBD was evaluated using Cox proportional hazard models, and presented as adjusted hazard ratios (aHRs) with 95% CIs. RESULTS: During a mean follow-up period of 7.3 years, 1419 patients (0.014%) developed CD and 5897 patients (0.059%) developed UC. The incidences of CD (per 100,000 person-years) were 3.756, 2.248, and 2.346 in patients with AD, AR, or asthma, respectively. The incidences of UC were 11.952, 9.818, and 9.358 in patients with AD, AR, or asthma, respectively. Multivariable analysis revealed that the aHRs for incident CD in patients with AD, AR, or asthma were 2.02, 1.33, and 1.60 (95% CIs, 1.118-3.663, 1.149-1.529, and 1.193-2.136, respectively) compared with controls. The risks of incident UC in patients with AD, AR, or asthma were 1.51, 1.32, and 1.29 (95% CIs, 1.082-2.104, 1.229-1.410, and 1.115-1.491, respectively) compared with controls. Moreover, an increase in the number of atopic diseases gradually increased the risk for CD and UC; for 1 or 2 or more atopic diseases, the aHRs for CD were 1.35 and 1.65 (95% CIs, 1.171-1.560 and 1.146-2.376), and the aHRs for UC were 1.30 and 1.49 (95% CIs, 1.211-1.392 and 1.249-1.774), respectively. CONCLUSIONS: Based on a nationwide population-based study in Korea, patients with any atopic disease, including AD, AR, or asthma, have an increased risk for CD and UC. The risk for IBD increases with the increase in the number of atopic diseases.
引用
- Soh H, Lee HJ, Han K, et al. Atopic Diseases Are Associated With Development of Inflammatory Bowel Diseases in Korea: A Nationwide Population-based Study. Clin Gastroenterol Hepatol. 2020. PMID: 32712393. doi:10.1016/j.cgh.2020.07.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。